Stay updated on Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe footer now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating the current software version of the site.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision version was updated from v3.5.2 to v3.5.3, representing a new site release. It does not change the study information presented on the page.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a site version update with no visible edits to study details, investigators, or listed locations.SummaryDifference0.0%

- Check78 days agoChange DetectedThe UI now displays Revision: v3.5.0 in place of Revision: v3.4.3, reflecting a minor site revision.SummaryDifference0.0%

- Check85 days agoChange DetectedFooter shows revision: v3.4.3, replacing the previous v3.4.2 tag.SummaryDifference0.0%

- Check114 days agoChange DetectedAdded site revision tag 'Revision: v3.4.2' and removed the government funding status notice along with the earlier 'Revision: v3.4.1' entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.